Literature DB >> 16256012

Obstructive sleep apnea and hypertension.

Krzysztof Narkiewicz1, Jacek Wolf, Francisco Lopez-Jimenez, Virend K Somers.   

Abstract

There is growing evidence of a causal relationship between obstructive sleep apnea (OSA) and hypertension. Untreated OSA may have direct and deleterious effects on cardiovascular function and structure through several mechanisms, including sympathetic activation, oxidative stress, inflammation, and endothelial dysfunction. OSA may contribute to or augment elevated blood pressure levels in a large proportion of the hypertensive patient population. It is important to consider OSA in the differential diagnosis of hypertensive patients who are obese. OSA should be especially considered in those hypertensive patients who respond poorly to combination therapy with antihypertensive medications.

Entities:  

Mesh:

Year:  2005        PMID: 16256012     DOI: 10.1007/s11886-005-0061-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  50 in total

1.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

2.  Sympathetic-nerve activity during sleep in normal subjects.

Authors:  V K Somers; M E Dyken; A L Mark; F M Abboud
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

3.  Sleep-disordered breathing and hypertension among African Americans.

Authors:  G Jean-Louis; F Zizi; G Casimir; J DiPalma; R Mukherji
Journal:  J Hum Hypertens       Date:  2005-06       Impact factor: 3.012

4.  Early signs of atherosclerosis in obstructive sleep apnea.

Authors:  Luciano F Drager; Luiz A Bortolotto; Maria Cecília Lorenzi; Adelaide C Figueiredo; Eduardo M Krieger; Geraldo Lorenzi-Filho
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

5.  Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study.

Authors:  Donald C Haas; Gregory L Foster; F Javier Nieto; Susan Redline; Helaine E Resnick; John A Robbins; Terry Young; Thomas G Pickering
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

6.  Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study.

Authors:  J P Singh; M G Larson; H Tsuji; J C Evans; C J O'Donnell; D Levy
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

7.  Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea.

Authors:  I Wilcox; R R Grunstein; J A Hedner; J Doyle; F L Collins; P J Fletcher; D T Kelly; C E Sullivan
Journal:  Sleep       Date:  1993-09       Impact factor: 5.849

8.  Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Susan M Harding
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

Review 9.  Obesity, sleep apnea, and hypertension.

Authors:  Robert Wolk; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  17 in total

1.  High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea.

Authors:  C A Schaefer; L Adam; J Weisser-Thomas; S Pingel; G Vogel; U Klarmann-Schulz; G Nickenig; C Pizarro; D Skowasch
Journal:  Clin Res Cardiol       Date:  2015-03-01       Impact factor: 5.460

2.  Role of angiotensin-converting enzyme 1 within the median preoptic nucleus following chronic intermittent hypoxia.

Authors:  Katelynn Faulk; Brent Shell; T Prashant Nedungadi; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-21       Impact factor: 3.619

3.  [Screening for sleep apnea in cardiovascular patients in clinical routine].

Authors:  W S Mäuser; S Sandrock; L Kotzott; H Bonnemeier
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

4.  Generation of active expiration by serotoninergic mechanisms of the ventral medulla of rats.

Authors:  Eduardo V Lemes; Eduardo Colombari; Daniel B Zoccal
Journal:  J Appl Physiol (1985)       Date:  2016-09-22

5.  Obstructive sleep apnea as a risk factor for preeclampsia-eclampsia.

Authors:  Nattapong Jaimchariyatam; Kunyalak Na-Rungsri; Somkanya Tungsanga; Somrat Lertmaharit; Vitool Lohsoonthorn; Surachart Totienchai
Journal:  Sleep Breath       Date:  2018-11-27       Impact factor: 2.816

6.  Breathing variability at rest is positively associated with 24-h blood pressure level.

Authors:  David E Anderson; Jessica D McNeely; Margaret A Chesney; Beverly G Windham
Journal:  Am J Hypertens       Date:  2008-09-25       Impact factor: 2.689

Review 7.  Sympathetic neural mechanisms in human hypertension.

Authors:  Ronald G Victor; Moiz M Shafiq
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 8.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

9.  Are sleep symptoms predictors of resistant hypertension in a population-based sample? Findings from the National Health and Nutritional Examination Survey.

Authors:  Harneet Walia; Kingman Strohl; Brian Koo; Andreea Seicean; Sinziana Seicean
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-18       Impact factor: 3.738

10.  Assessment of respiratory effort with EMG extracted from ECG recordings during prolonged breath holds: Insights into obstructive apnea and extreme physiology.

Authors:  Mark Stewart; Anthony R Bain
Journal:  Physiol Rep       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.